Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Entain plc ( (GB:ENT) ).
Entain plc has upgraded its financial guidance for BetMGM, its joint venture with MGM Resorts, for the fiscal year 2025 due to continued strong momentum and net revenue growth in both iGaming and online sports betting. The revised guidance anticipates at least $2.6 billion in net revenue and a minimum of $100 million in EBITDA, reflecting increased confidence in BetMGM’s performance and future growth prospects, which are expected to contribute significantly to the company’s strategic goals.
The most recent analyst rating on (GB:ENT) stock is a Buy with a £8.00 price target. To see the full list of analyst forecasts on Entain plc stock, see the GB:ENT Stock Forecast page.
Spark’s Take on GB:ENT Stock
According to Spark, TipRanks’ AI Analyst, GB:ENT is a Neutral.
Entain plc’s overall stock score is driven by robust revenue growth and cash flow management, offset by significant profitability challenges and high leverage. Positive corporate events provide strategic optimism, but weak technical indicators and valuation concerns temper the overall score.
To see Spark’s full report on GB:ENT stock, click here.
More about Entain plc
Entain plc is a leading global sports betting and gaming group, operating both online and in retail sectors. The company owns a diverse portfolio of established brands in sports and gaming, including BetCity, bwin, Coral, Ladbrokes, and PartyCasino, among others. Entain operates a 50/50 joint venture with MGM Resorts International called BetMGM, which is a prominent player in the US sports betting and iGaming market. The company is headquartered in the UK and focuses on operating in domestically regulated markets.
Average Trading Volume: 2,642,767
Technical Sentiment Signal: Hold
Current Market Cap: £4.81B
See more data about ENT stock on TipRanks’ Stock Analysis page.